Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1220 in its research report dated January 31, 2023.
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1240 in its research report dated November 02, 2022.
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1000 in its research report dated February 01, 2022.
We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturers
Centrum Research recommended hold rating on Sun Pharma with a target price of Rs 530 in its research report dated May 31, 2018.
Centrum recommended hold rating on Sun Pharma with a target price of Rs 490 in its research report dated November 18, 2017.
Nirmal Bang has come out with its report on stock ideas for 2013.